Last updated 6 months ago by Michael Darmanin
Researchers from Utrecht University, together with fellow researchers from Erasmus MC and biotech company Harbor BioMed, have developed a human antibody that can inhibit the new coronavirus (SARS-CoV-2) which causes the respiratory disease otherwise known as COVID-19.
Research leader Berend-Jan Bosch of the Utrecht University does not want to raise false expectations. It is a promising first step in the journey towards a cure however it is far too early to speculate about the potential efficacy in humans. The research is being reviewed by a leading scientific journal. Further comments can be provided once the article has been accepted.